Cargando…
The molecular landscape of premenopausal breast cancer
INTRODUCTION: Breast cancer in premenopausal women (preM) is frequently associated with worse prognosis compared to that in postmenopausal women (postM), and there is evidence that preM estrogen receptor-positive (ER+) tumors may respond poorly to endocrine therapy. There is, however, a paucity of s...
Autores principales: | Liao, Serena, Hartmaier, Ryan J., McGuire, Kandace P., Puhalla, Shannon L., Luthra, Soumya, Chandran, Uma R., Ma, Tianzhou, Bhargava, Rohit, Modugno, Francesmary, Davidson, Nancy E., Benz, Steve, Lee, Adrian V., Tseng, George C., Oesterreich, Steffi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531812/ https://www.ncbi.nlm.nih.gov/pubmed/26251034 http://dx.doi.org/10.1186/s13058-015-0618-8 |
Ejemplares similares
-
Improving ChIP-seq peak-calling for functional co-regulator binding by integrating multiple sources of biological information
por: Osmanbeyoglu, Hatice Ulku, et al.
Publicado: (2012) -
Plasma lipids in premenopausal women with mammographic dysplasia.
por: Boyd, N. F., et al.
Publicado: (1989) -
Functional Interaction of Histone Deacetylase 5 (HDAC5) and Lysine-specific Demethylase 1 (LSD1) Promotes Breast Cancer Progression
por: Cao, Chunyu, et al.
Publicado: (2016) -
A rare case of tumor-to-tumor metastasis: breast cancer metastatic to a benign renal mass
por: Diego, Emilia, et al.
Publicado: (2013) -
Targeted mutation detection in breast cancer using MammaSeq™
por: Smith, Nicholas G., et al.
Publicado: (2019)